Neil Anthony PEGG,David Michel Adrien TADDEI,Jonathan SHANNON,Silvia PAOLETTA,Ting QIN,Gareth HARBOTTLE
申请号:
US16341650
公开号:
US20190263788A1
申请日:
2017.10.18
申请国别(地区):
US
年份:
2019
代理人:
摘要:
A compound which is a benzimidazole of formula (I): wherein X is a 5-membered heteroaryl group selected from the following: or a pharmaceutically acceptable salt thereof. The compound has activity in modulating the activity of p300 and/or CBP and is used to treat cancer, particularly prostate cancer.